WAY-100635

From WikiMD's WELLNESSPEDIA

Chemical structure of WAY-100635

WAY-100635 is a chemical compound that acts as a selective antagonist of the 5-HT1A receptor, a subtype of the serotonin receptor. It is widely used in scientific research to study the role of 5-HT1A receptors in various physiological and pathological processes.

Pharmacology[edit]

WAY-100635 is known for its high affinity and selectivity for the 5-HT1A receptor. It binds to this receptor and blocks the action of serotonin, a neurotransmitter that plays a crucial role in mood regulation, anxiety, and other central nervous system functions. By inhibiting the 5-HT1A receptor, WAY-100635 is used to investigate the effects of serotonin in the brain and to explore potential therapeutic targets for psychiatric disorders.

Uses in Research[edit]

In neuroscience research, WAY-100635 is employed to understand the involvement of 5-HT1A receptors in various conditions such as depression, anxiety disorders, and schizophrenia. It is also used in preclinical studies to evaluate the efficacy of new drugs targeting the serotonin system.

Imaging Studies[edit]

WAY-100635 is utilized in positron emission tomography (PET) imaging studies to visualize and quantify 5-HT1A receptor distribution in the brain. Radiolabeled derivatives of WAY-100635, such as [11C]WAY-100635, are used as tracers in these imaging studies, providing valuable insights into receptor density and function in both healthy and diseased states.

Mechanism of Action[edit]

As a 5-HT1A receptor antagonist, WAY-100635 prevents serotonin from binding to and activating this receptor. The 5-HT1A receptor is a G protein-coupled receptor that, when activated by serotonin, can inhibit the release of certain neurotransmitters and modulate neuronal excitability. By blocking this receptor, WAY-100635 can alter neurotransmitter release and neuronal activity, which is useful for dissecting the role of serotonin in various neural circuits.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.